Safety and Efficacy of Topiramate in Neonates With Hypoxic Ischemic Encephalopathy Treated With Hypothermia (NeoNATI)

This study is currently recruiting participants.

Verified January 2012 by Azienda Ospedaliero, Universitaria Meyer

Sponsor:

Collaborator:

Azienda Ospedaliero, Universitaria Pisana

Information provided by (Responsible Party):

Luca Filippi, Azienda Ospedaliero, Universitaria Meyer

ClinicalTrials.gov Identifier:

NCT01241019

First received: November 10, 2010

Last updated: January 22, 2012

Last verified: January 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	August 2013
Estimated Primary Completion Date:	February 2012 (Final data collection date for primary outcome measure)

No publications provided by Azienda Ospedaliero, Universitaria Meyer

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Filippi L, Fiorini P, Daniotti M, Catarzi S, Savelli S, Fonda C, Bartalena L, Boldrini A, Giampietri M, Scaramuzzo R, Papoff P, Del Balzo F, Spalice A, la Marca G, Malvagia S, Della Bona ML, Donzelli G, Tinelli F, Cioni G, Pisano T, Falchi M, Guerrini R. Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI). BMC Pediatr. 2012 Sep 5;12:144. doi: 10.1186/1471-2431-12-144.

To Top